Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) - Total Liabilities

Latest as of June 2025: ILA27.50 Million ILA ≈ $73.72K USD

Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has total liabilities worth ILA27.50 Million ILA (≈ $73.72K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See working capital to net assets of Tikun Olam Cannbit Pharmaceuticals Ltd to evaluate short-term liquidity relative to the company's equity base.

Tikun Olam Cannbit Pharmaceuticals Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see TKUN current and non-current assets.

Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Tikun Olam Cannbit Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Bonava AB (publ) ST:BONAV-A	Sweden	Skr9.17 Billion
Ascent Solar Technologies, Inc. NASDAQ:ASTI	USA	$2.83 Million
ABVC Biopharma Inc NASDAQ:ABVC	USA	$7.13 Million
eHealth Inc NASDAQ:EHTH	USA	$617.23 Million
Korea Eng Cons KO:023350	Korea	₩270.72 Billion
Pico (Thailand) Public Company Limited BK:PICO	Thailand	฿259.55 Million
Megachem (Thailand) Public Company Limited BK:MGT	Thailand	฿330.14 Million
Aquaron Acquisition Corp. Common Stock NASDAQ:AQU	USA	$5.64 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Tikun Olam Cannbit Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.20	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-2.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	3.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tikun Olam Cannbit Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)

The table below shows the annual total liabilities of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	ILA29.36 Million ≈ $78.70K	-32.56%
2023-12-31	ILA43.53 Million ≈ $116.70K	+9.09%
2022-12-31	ILA39.90 Million ≈ $106.98K	-13.17%
2021-12-31	ILA45.96 Million ≈ $123.21K	-21.78%
2020-12-31	ILA58.75 Million ≈ $157.51K	+5.75%
2019-12-31	ILA55.56 Million ≈ $148.94K	+692.75%
2018-12-31	ILA7.01 Million ≈ $18.79K	+1048.85%
2017-12-31	ILA610.00K ≈ $1.64K	--

About Tikun Olam Cannbit Pharmaceuticals Ltd

TA:TKUN Israel Drug Manufacturers - Specialty & Generic

Market Cap

$15.56 Billion

ILA5.80 Trillion ILA

Market Cap Rank

#24070 Global

#334 in Israel

Share Price

ILA68300.00

Change (1 day)

-23.77%

52-Week Range

ILA17.03 - ILA89600.00

All Time High

ILA89600.00